Cyclacel Pharmaceuticals, Inc.https://pcaobus.org/form-ap-filings/37392/37392Cyclacel Pharmaceuticals, Inc.373923/31/2019 12:56:36 PM201858b5c66a-2f4e-470e-99a8-b7527ec7703849RSM US LLP142516Cyclacel Pharmaceuticals, Inc.1130166CYCC; CYCCP0004926600Patrick George Gillespie0004926600True
VectoIQ Acquisition Corp.https://pcaobus.org/form-ap-filings/37391/37391VectoIQ Acquisition Corp.373913/31/2019 12:50:38 PM2018df8fac74-5a3f-44dc-a540-2b3d3d9f100d49RSM US LLP707933VectoIQ Acquisition Corp.1731289VTIQU; VTIQW; VTIQ0004926600Patrick George Gillespie0004926600True
VectoIQ Acquisition Corp.https://pcaobus.org/form-ap-filings/25659/25659VectoIQ Acquisition Corp.256595/30/2018 3:13:27 PM2018163c37c3-69b8-4f50-8e62-ec0110737ed949RSM US LLP707933VectoIQ Acquisition Corp.1731289VTIQU; VTIQW; VTIQ0004926600Patrick George Gillespie0004926600True
VectoIQ Acquisition Corp.https://pcaobus.org/form-ap-filings/25380/25380VectoIQ Acquisition Corp.253805/21/2018 5:49:43 PM2018e912e628-207e-4cb3-8c4c-2728ddc86dc449RSM US LLP707933VectoIQ Acquisition Corp.1731289VTIQU; VTIQW; VTIQ0004926600Patrick George Gillespie0004926600True
VectoIQ Acquisition Corp.https://pcaobus.org/form-ap-filings/23017/23017VectoIQ Acquisition Corp.230174/20/2018 9:45:59 PM2018dfff527b-d55c-4162-a533-02f887080b5a49RSM US LLP707933VectoIQ Acquisition Corp.1731289VTIQU; VTIQW; VTIQ0004926600Patrick George Gillespie0004926600True